The healthcare industry is evolving rapidly with the adoption of artificial intelligence (AI) in
areas such as screening and diagnostics, drug and therapy, and administration. However,
AI’s impact on the industry can only be maximized once expanded beyond single-point use
cases to directly address outcome-focused patient care.

This white paper describes the transformative capabilities of Medical AI, a DeLorean AI (DAI)
solution, piloted in seventeen(17) Innovative Renal Care (IRC) dialysis centers over a
3-month period. The following will highlight the AI solution’s capacity to predict missed
treatments, hospitalizations due to fluid overload, as well as other key measures such as
adequate clearance and anemia management. By integrating Medical AI into daily
workflows of clinical staff, IRC improved patient outcomes, enhanced treatment adherence,
and optimized resource allocation.

DeLorean Artificial Intelligence’s Medical AI has achieved demonstrable benefits after being
deployed within IRC centers. Benefits include predicting missed treatments and upcoming
hospitalizations, enhancing patient outcomes, and reducing healthcare costs. In addition to
direct use for managing patient risk at the point of care, results are also being used to inform
treatment and care planning as well as Quality Assurance and Process Improvement (QAPI)
retrospectives.